News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Bayer AG’s Inhaler Drug Gets Thumbs Up in Test
May 20, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, May 20 (Reuters) - Bayer's (BAYG.DE: Quote, Profile, Research) experimental inhaler drug looked set to become a hit after a study of the device that patients use to inhale the antibiotic showed promising results, analysts said on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase II
Europe
Nektar Therapeutics
MORE ON THIS TOPIC
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
April 29, 2025
·
2 min read
·
Tristan Manalac
Bladder cancer
Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint
April 28, 2025
·
1 min read
·
Tristan Manalac
Bladder cancer
J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo
April 28, 2025
·
2 min read
·
Tristan Manalac
Cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
April 28, 2025
·
1 min read
·
Tristan Manalac
